Closed-loop flow control for microfluidic 3D bioprinting

Aspect Biosystems is developing a novel microfluidic 3D bioprinting technology that has the potential to fundamentally change the way many diseases are treated through the creation of functional human tissue. The technology manages highly complex fluid handling operations and requires sophisticated control systems to deliver reliable and repeatable results. This project is focused on developing such a control system specifically for fluid flow control through the microfluidic printhead. A successful, sophisticated flow control system comprises critical technology that will be essential for realizing clinical applications and is an important step toward realizing the full potential of the technology.

Faculty Supervisor:

Jason Hein

Student:

Sebastian Steiner

Partner:

Aspect Biosystems Ltd

Discipline:

Chemistry

Sector:

Medical devices

University:

University of British Columbia